ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
GeNeuro SA

GeNeuro SA (GNRO)

0,137
0,006
(4,58%)
Geschlossen 08 Februar 5:30PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,137
Gebot
0,13
Fragen
0,148
Volumen
666.534
0,1255 Tagesbereich 0,18
0,0428 52-Wochen-Bereich 2,35
Marktkapitalisierung
Handelsende
0,131
Handelsbeginn
0,1295
Letzte Trade
1475
@
0.137
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
450.785
Ausgegebene Aktien
29.760.933
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
-
Nettogewinn
-14,76M

Über GeNeuro SA

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Geneva, Che
Gegründet
-
GeNeuro SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNRO. The last closing price for GeNeuro was 0,13 €. Over the last year, GeNeuro shares have traded in a share price range of 0,0428 € to 2,35 €.

GeNeuro currently has 29.760.933 shares in issue. The market capitalisation of GeNeuro is 3,90 € million.

GNRO Neueste Nachrichten

GeNeuro SA annonce la prolongation du sursis concordataire provisoire

Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, annonce que le...

De nouvelles données soutenant une nouvelle approche de médecine de précision pour les patients atteints de SLA avec le GNK-301 de GeNeuro présentées lors du 35e Symposium international sur la SLA/MMN

Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), société biopharmaceutique dont l'objectif est de s'attaquer aux facteurs de progression des maladies neurodégénératives et...

GeNeuro SA Obtains the Opening of Debt-Restructuring Proceedings

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces that the Geneva...

GeNeuro: New Data Presented at the ECTRIMS 2025 Congress in Copenhagen Shows That Temelimab Rescues the Neurodegenerative Effects of HERV-W in an MS Model

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the progression of neurodegenerative and autoimmune...

GeNeuro annonce déposer une requête de sursis concordataire au Tribunal de première instance de Genève

Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.027-16.46341463410.1640.180.12552280020.14316007DE
40.0021.481481481480.1350.2420.1115158570.16720737DE
120.064288.18681318680.07280.280.04284507850.14204758DE
260.072110.7692307690.0650.280.04282149420.13649147DE
52-0.983-87.76785714291.122.350.04281346970.18323786DE
156-3.443-96.17318435753.584.010.0428482720.31169776DE
260-3.323-96.04046242773.466.280.0428326400.63668057DE

GNRO - Frequently Asked Questions (FAQ)

What is the current GeNeuro share price?
The current share price of GeNeuro is 0,137 €
How many GeNeuro shares are in issue?
GeNeuro has 29.760.933 shares in issue
What is the market cap of GeNeuro?
The market capitalisation of GeNeuro is EUR 3,9M
What is the 1 year trading range for GeNeuro share price?
GeNeuro has traded in the range of 0,0428 € to 2,35 € during the past year
What is the reporting currency for GeNeuro?
GeNeuro reports financial results in EUR
What is the latest annual profit for GeNeuro?
The latest annual profit of GeNeuro is EUR -14,76M
What is the registered address of GeNeuro?
The registered address for GeNeuro is 18 CHEMIN DES AULX, PLAN-LES-OUATES, GENEVA, 1228
What is the GeNeuro website address?
The website address for GeNeuro is www.geneuro.com
Which industry sector does GeNeuro operate in?
GeNeuro operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ALCABCabasse SA
0,77 €
(67,39%)
93,29k
ALEXPOne Experience
0,496 €
(64,24%)
2,54k
VTRVitura
5,80 €
(62,92%)
2,37k
DMSBSDiagnostic Medical Systems
0,007 €
(40,00%)
15,1k
ALVERVergnet
0,0009 €
(28,57%)
23,09M
ALCYBCybergun
0,0001 €
(-50,00%)
18,59M
BAIOdyssey Acquisition SA
0,1285 €
(-49,80%)
834,05k
ALALOAcheterLouerFR
0,0148 €
(-34,80%)
2,31M
MLWEYWeya
0,018 €
(-33,33%)
52,31k
MLCOTCoretech 5
0,0335 €
(-33,00%)
61k
ATOAtos SE
0,0021 €
(0,00%)
1,12B
ALVERVergnet
0,0009 €
(28,57%)
23,09M
ALCYBCybergun
0,0001 €
(-50,00%)
18,59M
ALHGLouis Hachette Group
1,331 €
(-2,90%)
11,49M
BCPBanco Comercial Portugues SA
0,5008 €
(-1,14%)
10,67M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock